secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001493152-23-002940
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs issues $7.6M unsecured note to JXVII Trust, 10% interest, matures Jan 2026
--------------------------------------------------------------------------------

- Principal $7.6M, 10% annual interest payable quarterly, maturity Jan 27, 2026.
- Warrant issued for 76,000 shares at $9.00/share, exercisable for 5 years.
- Proceeds for working capital, capex, product development, and potential acquisitions.
- Guaranteed by subsidiary Pharmaloz Manufacturing; customary default and covenant provisions.
- Prepayment allowed anytime without premium or penalty upon 7 days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/0001493152-23-002940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer